GastroenterologyRx (Retseptli)

Gepa-L

Dosage form:Granules for preparation of solution for oral administration 5g No. 30 (bags)
Category:Gastroenterology

Indications for Use

For hyperammonemia resulting from acute or chronic liver damage (cirrhosis, liver steatosis, hepatitis), especially for the treatment of impaired consciousness (precomatose state) or neurological complications (hepatic encephalopathy).

Composition & Active Ingredient

Active Ingredient: L-ornithine-L-aspartate
Composition: Each 10 ml of infusion solution contains: active substance — L-ornithine-L-aspartate 5 g; excipients — sodium metabisulfite, water for injection.

Dosage & Administration

Dosage: As prescribed by a physician, on average 4 ampoules per day. In case of impaired consciousness (precoma and coma) — up to 8 ampoules per day, depending on the severity of the patient's condition. Maximum infusion rate — 5 g/hour.
Usage Instructions: Hepa-L can be added to all standard infusion solutions. Due to the risk of venous intolerance, the dose should not exceed 6 ampoules in 500 ml of infusion. Not recommended for use in children under 8 years old.

Contraindications

Hypersensitivity to the active and excipient substances of the drug. Certain kidney diseases (when serum creatinine concentration is above 3 mg/100 ml).

Storage & Packaging

Storage Conditions: Store at a temperature not exceeding 25°C, protected from light, out of reach of children. Do not freeze. Shelf life — 2 years.
Package Description: Dosage form and package: Granules for preparation of solution for oral administration 5g No. 30 (bags)
PDF

Official Medical Leaflet

Approved PDF Document • Complete Prescribing Info

Open Medical Leaflet (PDF)

Medical Disclaimer: All information provided on this website is for educational purposes only and does not substitute professional medical advice. Consult a healthcare professional and read the official packaging insert before use.

Related Products